XML 66 R50.htm IDEA: XBRL DOCUMENT v3.25.1

RESEARCH AND DEVELOPMENT EXPENSES (Tables)

12 Months Ended

Dec. 31, 2024

RESEARCH AND DEVELOPMENT EXPENSES.

Schedule of research and development expenses

​

​	​	​	​	​	​	​
​	​	Year Ended December 31,
​		2024		2023		2022
​	​	U.S. dollars in thousands
Payroll and related expenses	​	222	​	390	​	661
Professional services		708		605	​	1,210
Share-based payments		156		138		1,151
Clinical and pre-clinical trials		114		1,891		3,872
Intellectual property development		238		222		180
Other		150		282		205
​		1,588		3,528		7,279

​

X

- Definition

The disclosure of research and development expense. [Refer: Research and development expense]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2024-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

n/a

+ References

No definition available.

+ Details

Name:	rdhl_IfrsResearchAndDevelopmentAbstract
Namespace Prefix:	rdhl_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration